Better Therapeutics, Inc. (BTTX) financial statements (2022 and earlier)

Company profile

Business Address 311 WEST 43RD STREET, 12TH FLOOR
NEW YORK, NY 10036
State of Incorp. DE
Fiscal Year End December 31
SIC 80 - Health Services (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments40,56625
Cash and cash equivalents40,56625
Prepaid expense4,409 
Deferred costs 62
Other current assets276 
Total current assets:45,25187
Noncurrent Assets
Property, plant and equipment82 
Other noncurrent assets548 
Other undisclosed noncurrent assets5,077 
Total noncurrent assets:5,707 
TOTAL ASSETS:50,95887
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,7331
Accounts payable1,523 
Accrued liabilities1,8581
Employee-related liabilities1,352 
Due to related parties 62
Total current liabilities:4,73363
Noncurrent Liabilities
Long-term debt and lease obligation9,505 
Long-term debt, excluding current maturities9,505 
Total noncurrent liabilities:9,505 
Total liabilities:14,23863
Stockholders' equity
Stockholders' equity attributable to parent36,72023
Common stock20
Additional paid in capital108,46125
Accumulated deficit(71,743)(2)
Total stockholders' equity:36,72023
TOTAL LIABILITIES AND EQUITY:50,95887

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
Operating expenses(30,560) 
Operating loss:(30,560) 
Interest and debt expense(185) 
Loss from continuing operations before equity method investments, income taxes:(30,745) 
Other undisclosed loss from continuing operations before income taxes(9,743) 
Loss from continuing operations before income taxes:(40,488) 
Income tax benefit153 
Net loss available to common stockholders, diluted:(40,335) 

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
Net loss:(40,335) 
Comprehensive loss, net of tax, attributable to parent:(40,335) 

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: